JPET #61192 5 1999; Brawley et al., 2000) . However, a recent study provided no evidence for the presence of functional β 3 -AR or l.a.s.β 1 -AR in rat aorta (Brahmadevara et al., 2003) . Indeed, the authors observed that CGP 12177 and BRL 37344 elicited relaxation in PHE-precontracted aortic rings, but failed to do so in those precontracted with prostaglandin F 2α (PGF 2α ). This study raises the question of the choice of the preconstrictor agent for investigation of β-ARmediated vasorelaxation and suggests a possible interference of some β-AR ligands with the α-AR signaling pathway (Brahmadevara et al., 2003) . The influence of the vasoconstrictor agent on the responses induced by β 3 -and atypical β-AR agonists was also noticed in rat mesenteric artery (Kozlowska et al., 2003) . According to these data, it appears that the presence of functional β 3 -and atypical β-AR in arteries are still under debate. Moreover, most of these studies were performed in arteries of systemic circulation, and relative few information is available in pulmonary circulation. In canine large pulmonary artery, the existence of a vasorelaxant β 3 -AR was proposed (Tamaoki et al., 1998) . In rat isolated perfused lung, it was shown that some selective β 3 -AR agonists (phenylethanolaminotetraline compounds) opposed the hypoxic vasoconstriction (Dumas et al., 1998) . However, the receptor involved in this effect did not fully match the β 3 -AR subtype.
The aim of the present study was therefore to evaluate the effect of CGP 12177 and the other aryloxypropanolamine β-AR ligands, bupranolol and SR 59230A, on the contraction of isolated rat intralobar pulmonary artery and to investigate a possible interaction of these β-AR ligands with the α 1 -AR. For this purpose, the functional responses induced by CGP 12177 were characterized in the absence and presence of α-or β-AR antagonists, and compared to those of PHE, the reference α 1 -AR agonist. The affinity of CGP 12177 and several β 3 -and atypical β-AR ligands towards the α 1 -AR was also determined using [ 3 H]-prazosin binding competition experiments. Preliminary accounts of this work have previously been published in abstract form (Leblais et al., 2003) .
Measurements of isometric tension
Male Wistar rats (450-600 g; 11-18 weeks old; from Elevage Janvier, Le Genest St Isle, France) and for some experiments female Wistar rats (290-310 g; 15 weeks old; from Elevage Janvier, Le Genest St Isle, France) were killed by CO 2 inhalation. After exsanguination, the heart and lungs were excised and placed in physiological salt solution (PSS) containing (in mM): NaCl 119; KCl 4.7; CaCl 2 1.5; MgSO 4 1.17; KH 2 PO 4 1.18; NaHCO 3 25 and glucose 5.5. Intralobar pulmonary arteries (2 nd -3 rd order branch; internal diameter: 450-850 µm) and, in some cases, extralobar pulmonary arteries (left and right main branches) were dissected free of connective tissue. Segments of 1.6 to 2 mm length were mounted in a Mulvany myograph (Multi Myograph System, model 610M, J.P. Trading, Aarhus, Denmark) and bathed in PSS maintained at 37°C and gassed with a mixture of 95% O 2 -5% CO 2 (pH 7.4).
The optimal resting tension for rat intralobar pulmonary arteries corresponds to an equivalent transmural pressure of 30 mmHg (Leach et al., 1992) . In order to determine this resting tension, a passive length-tension relationship was generated for each intralobar pulmonary artery. In the case of extralobar pulmonary arteries, vessels were progressively stretched to a resting tension of 3.7 mN. After 60 min of equilibration period under resting tone, viability of arteries was evaluated using PSS containing 80 mM KCl (equimolar substitution with NaCl).
Intralobar preparations developing a wall tension below 1 mN/mm were discarded.
After washouts, cumulative concentration-response curves were performed with either CGP 12177 (from 10 nM to 100 µM) or the α 1 -AR agonist PHE (from 1 nM to 100 µM) under different experimental conditions. In a first procedure, CGP 12177 or PHE was applied on the resting tone. In experiments evaluating the effect of CGP 12177 on the response induced by PHE, two consecutive concentration-response curves to PHE were performed. The second curve was conducted in the absence or presence of CGP 12177 (100 µM), added 15 min before PHE. In a second procedure, the concentration-response curves to CGP 12177 or PHE were performed in arteries precontracted with PGF 2α (3 µM or 30 µM, concentrations corresponding approximately to EC 15 and EC 80 , respectively). When indicated, preparations
were incubated with the α-AR antagonist phentolamine (1 µM), bupranolol (5 µM) or SR 59230A (1 or 3 µM) for 25 min before the carrying out of the concentration-response curve to CGP 12177 or PHE. In order to irreversibly inactivate α-AR, arteries were pre-treated by the alkylating agent phenoxybenzamine (PBZ) at 1 µM for 15 min. After PBZ pre-treatment, arteries were washed with PSS and experiments were performed as described above. In a third procedure, the CGP 12177 concentration-response curve was conducted in arteries precontracted with PHE (30 nM or 3 µM, concentrations corresponding approximately to EC 20 and EC 80 , respectively). At the end of each procedure, the presence of a functional endothelium was evaluated by the relaxant effect in response to application of acetylcholine (10 µM).
Measurements of intracellular calcium and external arterial diameter
Intralobar pulmonary arteries were removed from male Wistar rats, as described above.
Segments of 1 mm length were cannulated at both ends with glass micropipettes, secured with 10-0 nylon monofilament suture and placed in a microvasculature chamber (Living Systems, Burlington, VT, USA). Using a peristaltic pump and a pressure sensor, vessels were held at a constant transmural pressure of 15 mm Hg. The chamber was superfused at a rate of 2 ml/min with Krebs-Hepes solution (containing (in mM): NaCl 118.4; KCl 4.7; CaCl 2 2; MgSO 4 1.2; KH 2 PO 4 1.2; NaHCO 3 4; Hepes 10 and glucose 6; pH = 7.4 with NaOH) gassed with air and maintained at 37°C.
Arteries were loaded with fura-PE3 AM (an analogue of fura-2) by incubation in the microvascular chamber with 1 µM fura-PE3 AM in Krebs-Hepes solution for 90 min at 37°C.
After wash-out with Krebs-Hepes solution, the chamber was placed on the stage of an inverted epifluorescence microscope (Olympus IX70, France) equipped with a x10, Interfauna Ibérica, Barcelona, Spain) after decapitation. Cerebral cortex membranes were prepared as previously described (Madrero et al., 1996 
Drugs
Acetylcholine chloride, BRL 37344 sodium salt AM which were dissolved in dimethylsuphoxide (Sigma Chemical Co.) so that the final concentration of the solvent in contact with arteries was less than 0.05% for SR 59230A, and less than 0.1 % for fura-PE3 AM.
Data analysis
Isometric tension is expressed either as percentage of the initial tone (induced by PGF 2α or PHE) or percentage of the response to 80 mM KCl, as appropriate. To determine the potency of agonist, the EC 50 value (concentration that produces 50% of the maximum response) was Ligand competition curves were analyzed by non-linear regression (one-site model) with
Graph-Pad PRISM. pK i values were determined according to the Cheng and Prusoff equation (Cheng and Prusoff, 1973) .
Data are given as means ± S.E.M. Data were compared using a Student's t-test or a twoway analysis of variance (ANOVA) as appropriate. Differences were considered statistically significant when P<0.05.
Results

Influence of the precontractile agent on the response to CGP 12177 in rat pulmonary arteries
In a first set of experiments, the effect of CGP 12177 was determined in intralobar pulmonary arteries removed from male rats and precontracted with either 3 µM PGF 2α or 30 nM PHE (corresponding approximately to the EC 15 and EC 20 , respectively). The tension developed in response to these agents was not significantly different (tension: 14.6 ± 1.2 % of response to 80 mM KCl (n=14) with PGF 2α compared to 17.5 ± 4.9 % (n=4) with PHE). In arteries precontracted with 3 µM PGF 2α , addition of increasing concentrations of CGP 12177
further enhanced tension in a concentration-dependent manner ( Figure 1A&C ). In contrast, in arteries precontracted with 30 nM PHE, CGP 12177 induced a concentration-dependent relaxation ( Figure 1B&C ). Concentrations of CGP 12177 producing either contraction or relaxation were within the same range. A similar pattern of responses to CGP 12177 was still noticed when the concentration of precontractile agent was increased, namely 30 µM PGF 2α or 3 µM PHE (inducing comparable level of contraction and corresponding to the EC 80 value of each agonist). However, the amplitude of the responses were smaller: for 100 µM CGP 12177, tension reached 133 ± 5 % of PGF 2α -induced tone (n=6) and 80 ± 5 % of PHEinduced tone (n=5) (data not shown). The differential effect of CGP 12177 depending on the precontractile agent was not only observed in small intralobar pulmonary arteries but also in large extralobar pulmonary arteries (data not shown). In addition, CGP 12177 elicited similar qualitative and quantitative responses in intralobar pulmonary arteries removed from male or female rats. In arteries removed from female rats, the tension reached after addition of 100 µM CGP 12177 was 305 ± 13 % of PGF 2α (3 µM)-induced tone (n=3) and 74 ± 8 % of PHE (30 nM)-induced tone (n=3). These observations suggested that CGP 12177 may interact with α 1 -AR in rat pulmonary arteries. In subsequent experiments, the contractile effect of CGP 12177 was systematically compared with the one of PHE, the reference α 1 -AR agonist.
Influence of tone on the contractile effect of CGP 12177 and PHE in rat intralobar pulmonary artery
When applied on the basal tone, CGP 12177 exerted only minor effect in rat intralobar pulmonary arteries (Figure 2A ). By contrast, PHE caused a concentration-dependent contraction with a pD 2 value of 6.3 ± 0.1 (n=23; Figure 2B ). Precontraction with PGF 2α (3 µM) uncovered the contractile effect of CGP 12177 and markedly enhanced the PHE-induced contraction ( Figure 2A&B ). In PGF 2α -precontracted arteries, the pD 2 value of PHE was significantly increased (pD 2 = 7.7 ± 0.1, n=6; P<0.001 in comparison to pD 2 value of PHE on the basal tone), but its maximal response was not modified.
Effect of CGP 12177 on intracellular calcium concentration in rat intralobar pulmonary artery
In pressurized intralobar pulmonary arteries loaded with Fura-PE3, PGF 2α (3 µM) induced an increase in intracellular calcium concentration ( Figure 3A ) and a vasoconstriction ( Figure   3B ). Addition of CGP 12177 (1 to 100 µM) on PGF 2α -precontracted arteries induced a further increase in both the intracellular calcium concentration ( Figure 3A ) and contraction ( Figure   3B ).
Effect of CGP 12177 on the contractile response of PHE in rat intralobar pulmonary artery
The influence of CGP 12177 on the PHE-induced contraction was analyzed in nonprecontracted intralobar pulmonary arteries. A 15 min pretreatment with 100 µM CGP 12177 did not significantly affected the basal tone (4.7 ± 1.8 % of response to 80 mM KCl (n=8) compared to 2.5 ± 1.7 % in the absence of CGP 12177 (n=7)). In the presence of 100 µM CGP 12177, the concentration-response curve to PHE was significantly shifted to the right (pD 2 = 7.1 ± 0.1 (n=7) in the absence of CGP 12177, compared to 5.6 ± 0.1 (n=8) in the presence of CGP 12177; P<0.01), without any changes in the maximal response (Figure 4 ).
The pK B value of CGP12177 was estimated as 5.3.
Effect of α-AR antagonists on the contractile effect of CGP 12177 and PHE in PGF 2α -precontracted rat intralobar pulmonary artery
The potential role of α-AR in CGP 12177-induced contractile response was further investigated using α-AR antagonists. As expected, phentolamine (1 µM), a competitive α-AR antagonist, did not modify the tension induced by 3 µM PGF 2α (tension: 18.0 ± 2.3 % of response to 80 mM KCl (n=12) in the presence of phentolamine, compared to 14.6 ± 1.2 % (n=14) in the absence of phentolamine), but significantly shifted to the right the concentration-response curve to PHE (figure 5B; pD 2 = 5.8 ± 0.01 (n=6) in the presence of 1 µM phentolamine, compared to 7.7 ± 0.1 (n=6) in the absence of phentolamine; P<0.001).
The pK B value of phentolamine was estimated as 7.9. Phentolamine also inhibited CGP 12177-induced contractile response in PGF 2α -precontracted arteries ( Figure 5A ). The effect of another α-AR antagonist, the alkylating agent phenoxybenzamine (PBZ) that irreversibly inactivates α-AR, was also studied. A 15 min-pretreatment with 1 µM PBZ had no significant effect on the PGF 2α -induced contraction (tension: 19.3 ± 3.0 % of response to 80 mM KCl (n=8) after PBZ, compared to 14.6 ± 1.2 % (n=14) in the absence of PBZ). PBZ pretreatment abolished the PHE-induced vasoconstriction in PGF 2α -precontracted arteries ( Figure 6B ) and markedly reduced the CGP 12177-induced contractile response ( Figure 6A ). did not change the PGF 2α -induced tone (tension: 18.0 ± 2.6 % of response to 80 mM KCl (n=12) in the presence of bupranolol, compared to 14.6 ± 1.2 % (n=14) in the absence of bupranolol), but significantly decreased the CGP 12177-induced contraction ( Figure 7A ).
Effect of atypical
Furthermore, bupranolol caused a rightward shift of the concentration response-curve to PHE without modifying the maximal response ( Figure 7B ). The pD 2 value of PHE decreased from 7.7 ± 0.1 (n=6) in the absence of bupranolol to 6.9 ± 0.2 in the presence of bupranolol (n=6;
P<0.01). The estimated pK B value of bupranolol was 6.0.
In the presence of 3 µM SR 59230A (a drug commonly described as a selective β 3 -AR antagonist), the PGF 2α -induced tone was significantly increased (tension: 20.4 ± 2.7 % of response to 80 mM KCl (n=8) in the presence of 3 µM SR 59230A, compared to 14.6 ± 1.2 % (n=14) in the absence of SR 59230A; P<0.05) and the contractions induced by CGP 12177 and PHE were markedly depressed ( Figure 8A&B ). When the concentration of SR 59230A
was reduced to 1 µM, the PGF 2α -induced tone was not significantly altered (tension: 13.5 ± 1.1 % of response to 80 mM KCl (n=13) in the presence of 1 µM SR 59230A, compared to 14.6 ± 1.2 % (n=14) in the absence of SR 59230A), but the contractile response to CGP 12177 was still significantly inhibited, albeit to a lesser extent than with 3 µM SR 59230A
( Figure 8A ). SR 59230A (1 µM) also caused a significant rightward shift of the PHE concentration-response curve ( Figure 8B ). The pD 2 value of PHE diminished from 7.7 ± 0.1 (n=6) in the absence of SR 59230A to 6.4 ± 0.2 in the presence of SR 59230A (n=6; P<0.01), whereas the maximum contraction was not changed. The estimated pK B value of SR 59230A was 7.3.
Affinity of different AR ligands for [ 3 H]-prazosin binding sites
The affinities of some α-AR and β-AR ligands towards α 1 -AR were determined by Figure 9 and Table 1 ).
Discussion
The aim of this study was to determine the effect of CGP 12177 and the other aryloxypropanolamines, bupranolol and SR 59230A, on the contraction of rat pulmonary artery and the possible interaction of these ligands with α 1 -AR. CGP 12177 elicited a relaxation in PHE-precontracted arteries, had negligible effect when applied on basal tone, but further enhanced contraction and intracellular calcium concentration in PGF 2α -precontracted preparations. CGP 12177-induced contraction was inhibited by phentolamine and PBZ (α-AR antagonists) and also by bupranolol and SR 59230A. Moreover, CGP 12177, bupranolol and SR 59230A antagonized PHE-induced contraction. Finally, it is shown that CGP 12177, bupranolol and SR 59230A exhibited affinity for [ 3 H]-prazosin binding sites.
In this study, CGP 12177 induced relaxation for concentrations ≥ 1 µM in PHEprecontracted arteries. This is consistent with the potency of CGP 12177 in other rat arteries (Trochu et al., 1999; Brahmadevara et al., 2003; Kozlowska et al., 2003) . Recent reports highlight the influence of the precontractile agonist on the amplitude of the relaxant effect of some β-AR agonists. For instance, CGP 12177 produced relaxation in PHE-precontracted rat aorta, but failed to do so in PGF 2α -precontracted one (Brahmadevara et al., 2003) . Similarly, the relaxation evoked by cyanopindolol (another aryloxypropanolamine, non-conventional partial agonist) in rat mesenteric artery was strongly reduced in vessels constricted with PGF 2α , compared to those precontracted with PHE (Kozlowska et al., 2003) . In the present study, the effect of CGP 12177 was also evaluated in arteries precontracted with PGF 2α instead of PHE. Surprisingly, in these arteries, CGP 12177 exerted no relaxant effect, but rather induced contraction. These two opposite effects (contraction or relaxation) were observed within the same range of concentrations, suggesting a common underlying mechanism. To our knowledge, it is the first time that a contractile effect of CGP 12177 is reported. The use of relatively low concentrations of PGF 2α (producing only 15 % of its maximum response) might explain why contractile effects of CGP 12177 could be unmasked here. Accordingly, increasing pre-contraction level resulted in a marked reduction in the amplitude of CGP 12177-induced contraction.
Interference of CGP 12177 with α-AR or α-AR-mediated intracellular signaling pathway has been postulated from experiments showing that CGP 12177 produced relaxation in PHE-precontracted rat aorta, but not in those precontracted with PGF 2α (Brahmadevara et al., 2003) . The present study provides evidence for an interaction of CGP 12177 at the level of The lack of effect of CGP 12177 on basal tone (i.e., in the absence of PGF 2α ) seems a priori not consistent with α 1 -AR agonist properties of this compound. However, in conditions that unmasked the contractile properties of CGP 12177, PGF 2α increased the sensitivity to PHE. Different mechanisms may underlie PGF 2α -induced potentiation of α 1 -AR-mediated response. It has been reported that the vasoconstriction induced by stimulation of some receptors can be enhanced, or even uncovered, by increasing tone through Gq-protein coupled receptor pathway (Choppin and O'Connor, 1995; Movahedi and Purdy, 1997) . Several studies have shown that the vasoconstriction induced by α-AR stimulation can be potentiated by agonists of other G-protein coupled receptors (Fabi et al., 1998; Bhattacharya and Roberts, 2003) . Different mechanisms are proposed to explain this kind of potentiation, like tyrosine kinase/protein kinase C-dependent pathway (Henrion and Laher, 1994) , a RhoA/Rho kinase pathway (Boer et al., 2002) or the ERK-MAP kinase cascade (Bhattacharya and Roberts, 2003) . The implication of these pathways in enhanced sensitivity to PHE in PGF 2α -precontracted pulmonary arteries remains to be investigated. This phenomenon could have relevant pathological implications, especially in pulmonary hypertension which is characterized by an increase in vascular tone (Strange et al., 2002) . Whatever the mechanisms of potentiation, the disclosure of the contractile properties of CGP 12177 by PGF 2α could be related to a low intrinsic efficacy of CGP 12177 on α 1 -AR. Indeed, one would expect that conditions producing potentiation of the effect of a full agonist would uncover the response to a partial agonist. As a partial agonist behaves as an antagonist in the presence of a full agonist (Kenakin, 1993), we also investigated the antagonist properties of CGP 12177 for α 1 -AR. In conditions in which it had only minor effect per se on contraction (i.e., in the absence of In this study, other aryloxypropanolamines were evaluated as potential α-AR ligands.
Recently, it has been reported that bupranolol (a non-selective β-AR antagonist) and SR 59230A (a selective β 3 -AR antagonist) elicited relaxation in PHE-precontracted rat aorta, but not in PGF 2α -precontracted one (Brahmadevara et al., 2003) . This suggests that, like CGP 12177, bupranolol and SR 59230A interfere with the α 1 -AR signaling pathway (Brahmadevara et al., 2003) . The present study shows that bupranolol and SR 59230A both antagonized PHE-induced contraction in intralobar pulmonary artery (pK B values of 6.0 and 7.3, respectively) and displaced specific [ Competition experiments presented here show that, in contrast to CGP 12177, bupranolol and SR 59230A, BRL 37344 and CL 316243 displayed very low affinity for α 1 -AR.
Interestingly, BRL 37344 and CL 316243 exhibited weak potency and efficacy in relaxing PHE-precontracted rat mesenteric arteries (Kozlowska et al., 2003) . This might be related to the weak displacement of PHE from vascular α 1 -AR by CL 316243 and BRL 37344, owing to the low binding affinity of these two latter agents for α 1 -AR. CL 316243 and BRL 37344 are phenylethanolamine derivatives, whereas CGP 12177, bupranolol and SR 59230A are aryloxypropanolamine ones (Nisoli et al., 1996; Strosberg, 1997) . Aryloxypropanolamines likely share structural features responsible for interaction with α-AR. A detailed structureactivity relationship would be necessary to clarify the molecular requirements for concomitantly binding to α-AR and β-AR. Nevertheless, phenylethanolamine derivatives appear more suitable tools than aryloxypropanolamines to investigate the role of β 3 -AR in the vasculature.
In conclusion, this study gives more insight into the pharmacological properties of several 
